BioSpace News Archive

Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, today announced that William Collier, Arbutus’ President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 1:30 PM ET. A live webcast of the presentation can be accessed through the Investors section

Nascent Biotech, Inc is pleased to announce that the Company will soon begin Phase 1 clinical trials for a treatment of Brain Cancer, including, glioblastoma, the deadliest form of brain cancer.

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies and the utilization of novel biomarkers to enhance patient selection, today announced that the company will present at the Jefferies 2020 Virtual Healthcare Conference. The presentation is scheduled for Tuesday, June 2, 2020 from 2:00 – 2:25 pm Eastern Time. A webc

Annovis Bio Inc. announced that it filed a patent application with the U.S. Patent & Trademark Office concerning a method of inhibiting, preventing, or treating neurological injuries due to viral, bacterial, fungal, protozoan, or parasitic infections in humans and in animals via administration of ANVS401 or related compounds.

ChromaDex joins industry leaders to discuss “What New Dietary Ingredient Master Files Mean for Innovation & Compliance”

Calithera Biosciences, Inc. announced that Susan Molineaux, Ph.D., the company’s founder, president and chief executive officer, will present at the Jefferies Virtual Healthcare Conference at 8:00 a.m. ET on Thursday, June 4, 2020.

FibroGen, Inc. announced that Enrique Conterno, Chief Executive Officer, will participate in fireside chats at the following virtual healthcare conferences

Completed acquisition of Movantik® from AstraZeneca on April 1, 2020, and initiated U.S. promotion with net revenues of $7.3 million in April

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto , President and Chief Executive Officer, will present at the Jefferies 2020 Healthcare Conference on Wednesday, June 3,

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson and Executive Vice President and Chief Financial Officer Suky Upadhyay will be participating in a fireside chat at the Goldman Sachs 41 st Annual Global Healthcare Conference on Tuesday